logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
O

Oras Alabas

University of Manchester
H指数:21
被引数:1,539

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Using biologic therapies as first-line systemic treatment for psoriasis: A cohort study following the target trial emulation framework from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)

将生物制剂作为银屑病的一线系统性治疗：一项基于目标试验模拟框架的队列研究，来自英国皮肤科医生生物制剂和免疫调节剂登记系统（BADBIR）

British Journal of Dermatology
IF9.6
2026-03-160
OA
Duc Binh Phan; Philip Laws; Catherine H Smith; Christopher E M Griffiths; Brian Kirby; Olivia Hughes; Gabriel Rogers; Oras A Alabas; Mark Lunt; Richard B Warren; Zenas Z N Yiu
Predictors of differential treatment response between adalimumab and methotrexate in psoriasis: a causal forest analysis of the British Association of Dermatologists Biologics and Immunomodulators Register

银屑病患者adalimumab与甲氨蝶呤差异化治疗反应的预测因子：英国皮肤科医生学会生物制剂和免疫调节剂登记研究的因果森林分析

BRITISH JOURNAL OF DERMATOLOGY
IF9.6
2025-07-010
OAAI
Haw, William W. Y.; Alabas, Oras A.; Sperrin, Matthew; Cina, Giovanni; Abu-Hanna, Ameen; Warren, Richard B.
Evaluating changes in baseline characteristics and drug-utilization pattern in patients with moderate-to-severe psoriasis: findings from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) cohort

评估中度至重度银屑病患者基线特征和药物使用模式的变化：英国皮肤科医师生物制剂和免疫调节剂登记研究（BADBIR）队列的研究结果

CLINICAL AND EXPERIMENTAL DERMATOLOGY
IF2.8
2025-07-012
OAAI
Alabas, Oras A.; Evans, Ian; Mcelhone, Kathleen; Yiu, Zenas Z. N.; Reynolds, Nick J.; Laws, Philip; Bewley, Anthony; Smith, Catherine H.; Lunt, Mark; Griffiths, Christopher E. M.; Warren, Richard B.
Drug survival of IL-23 and IL-17 inhibitors versus other biologics for psoriasis: A British Association of Dermatologists Biologics and Immunomodulators Register cohort study

IL-23和IL-17抑制剂与其他生物制剂治疗银屑病的药物生存率：一项英国皮肤科医师学会生物制剂和免疫调节剂登记研究队列研究

Journal of the European Academy of Dermatology and Venereology
IF8
2025-05-290
OA
Leila Motedayen Aval; Zenas Z. N. Yiu; Oras A. Alabas; Christopher E. M. Griffiths; Nick J. Reynolds; Philip J. Hampton; Catherine H. Smith
Age and biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)

年龄和生物学治疗生存率在患有中重度银屑病患者中的研究：一项来自英国皮肤科医师生物制剂和免疫调节剂登记处（BADBIR）的队列研究

BRITISH JOURNAL OF DERMATOLOGY
IF9.6
2025-01-100
PRE
Alabas, Oras A.; Mason, Kayleigh J.; Yiu, Zenas Z. N.; Smith, Catherine H.; Warren, Richard B.; Griffiths, Christopher E. M.; BADBIR Study Grp, Jonathan
Characteristics of 'super responders' and 'super nonresponders' to first biologic monotherapy for psoriasis: a nested case-control study

银屑病首次生物单药治疗的 “超级反应者” 和 “超级无反应者” 的特征: 巢式病例对照研究

BRITISH JOURNAL OF DERMATOLOGY
IF9.6
2023-11-110
OA
Mason, Kayleigh J.; Alabas, Oras A.; Dand, Nick; Warren, Richard B.; Reynolds, Nick J.; Barker, Jonathan N. W. N.; Yiu, Zenas Z. N.; Smith, Catherine H.; Griffiths, Christopher E. M.
Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies
BRITISH JOURNAL OF DERMATOLOGY
IF9.6
2023-11-012
OA
Abhishek, Abhishek; Stevenson, Matthew D.; Nakafero, Georgina; Grainge, Matthew J.; Evans, Ian; Alabas, Oras; Card, Tim; Taal, Maarten W.; Aithal, Guruprasad P.; Fox, Christopher P.; Mallen, Christian D.; van der Windt, Danielle A.; Riley, Richard D.; Warren, Richard B.; Williams, Hywel C.

研究方向

暂未获取到该数据
C
Chris P Gale
H 指数:80论文数:644被引数:9.3万
R
Richard B. Warren
H 指数:69论文数:705被引数:1.7万
Z
Zenas Z N Yiu
H 指数:31论文数:191被引数:3,967
C
C.E.M. Griffiths
H 指数:131论文数:1,295被引数:7.1万
C
Catherine Smith
H 指数:95论文数:747被引数:3.4万
N
Nick J. Reynolds
H 指数:60论文数:408被引数:1.3万
M
Marlous Hall
H 指数:30论文数:106被引数:2,828
T
Tatendashe Bernadette Dondo
H 指数:20论文数:40被引数:1,530
M
Mark de Belder
H 指数:61论文数:376被引数:1.4万
P
Peter Ludman
H 指数:58论文数:379被引数:1.3万